Trial intelligence / Profile preview

Budesonide nasal irrigation versus budesonide nasal spray in chronic rhinosinusitis with nasal polyps

RBR-9j3d9zPhase 2Recruiting

Sponsor
Federal University of São Paulo
Start
Jan 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of budesonide in chronic rhinosinusitis with nasal polyps (CRSwNP) (2 arms), sponsored by Federal University of São Paulo. Primary endpoint: Not reported. Started Jan 2018; status: recruiting.

02

Drugs

budesonide
03

Conditions

chronic rhinosinusitis with nasal polyps (CRSwNP)

Beyond the preview

Go deeper on RBR-9j3d9z.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-9j3d9z.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call